Skip to main content
Emapalumab Use in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: the REAL-HLH Study.
Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality.
Improving Health Equity in Rheumatology Through Workforce Diversification and Support for Health Equity Research and Education.
Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.
Renal Response Outcomes of the EuroLupus and NIH Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis.
Variation in Early Anakinra Use and Short-term Outcomes in Multisystem inflammatory Syndrome in Children.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.